US-Funded Kenyan AIDS Project Could Be Cash Cow for Multinational High Tech Firms
Though the U.S. may consider suspending some financial assistance that it sends to Kenya, such a freeze is not slated to affect a large-scale HIV/AIDS initiative that the U.S. plans to embark upon in that embattled African nation, a State Department spokesman said today. Consequently, multinational corporations such as Lockheed Martin, MAERSK Line, Bearing Point, and Chemonics likely are breathing a sigh of relief, as the technology divisions of those companies are seeking a piece of the $500,000,000 "Pharma Project" pie.
Dozens of representatives from these and other government contractors in Nov. 2007 attended a State Dept. conference in Nairobi to discuss potential contracting opportunities related to the endeavor, according to documents that The Peacock Report located through a routine search of the FedBizOpps database. However, this half-billion-dollar segment of the Pharma Project "will not entail actually procuring laboratory materials and equipment such as rapid test kits, reagents or machines," a presolicitation document shows. On the contrary, the document notes that funds instead will be used "to establish and operate a safe, secure, reliable, and sustainable supply-chain management system [emphasis added] to forecast, procure, store, and distribute the drugs, supplies, and equipment needed to provide care and treatment of persons with HIV/AIDS in Kenya."

